Injection of nerve growth factor into human masseter muscle evokes longlasting mechanical allodynia and hyperalgesia

被引:197
作者
Svensson, P
Cairns, BE
Wang, K
Arendt-Nielsen, L
机构
[1] Aarhus Univ, Dept Clin Oral Physiol, Sch Dent, DK-8000 Aarhus C, Denmark
[2] Aarhus Univ Hosp, Dept Maxillofacial Surg, DK-8000 Aarhus C, Denmark
[3] Harvard Univ, Sch Med, Dept Anesthesia, Childrens Hosp, Boston, MA 02115 USA
[4] Aalborg Univ, Orofacial Pain Lab, Ctr Sensory Motor Interact, DK-9220 Aalborg, Denmark
关键词
pain measurement; allodynia; orofacial pain; temporomandibular disorders pain; nerve growth factor;
D O I
10.1016/S0304-3959(03)00012-5
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Nerve growth factor (NGF) is a neurotrophic protein with a pivotal role in development and maintenance of the nervous system on one side and inflammatory and neuropathic pain states on the other. NGF causes clear signs of behavioral hyperalgesia in animal models and following intradermal and systemic administration in humans. The present double-blinded, placebo-controlled study was designed to test quantitatively the effect and duration (1 h, 1, 7, 14, 21 and 28 days) of NGF (5 mug in 0.2 ml) injected into the masseter muscle. Pressure pain thresholds (PPT) and pressure tolerance thresholds (PTOL) were used as indices of mechanical allodynia and hyperalgesia in the jaw-closing muscles. In addition, perceived pain intensity was assessed by the subjects on a 0-10 numerical rating scale (NRS) with the jaw at rest and in relation to various oral functions (chewing, yawning, talking, swallowing, drinking and smiling). Repeated measures analysis of variance (ANOVA) was used to test for significant effects. Injection of NGF into the masseter muscle was associated with significantly reduced PPT for 7 days (ANOVA: P < 0.001) and PTOL for 1 day (P < 0.001). Buffered isotonic saline injections into the masseter muscle also significantly lowered the PPT after 1 day but to a significantly smaller extent than the NGF injections (P < 0.001) and isotonic saline had no significant effects on PTOL. In contrast, assessment of PPT and PTOL in the non-injected temporalis muscles demonstrated a significant increase after 14-28 days (P < 0.001), which may have reflected an adaptation to the test procedure. NRS scores of chewing and yawning were significantly increased for 7 days following NGF injection (P < 0.001). Systemic adverse effects were noted in one subject who reported fever and slight discomfort about 8 h after the NGF injection. In conclusion, this is the first study to show that injection of NGF into the human masseter muscle causes local signs of mechanical allodynia and hyperalgesia that persist for at least 7 days as well as pain during strenuous jaw movement. The present pain model is safe and may be used to gain further insight into the neurobiological mechanisms of muscle pain and sensitization. (C) 2003 International Associaiton for the Study of Pain Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:241 / 247
页数:7
相关论文
共 45 条
  • [1] Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy - A randomized controled trial
    Apfel, SC
    Schwartz, S
    Adornato, BT
    Freeman, R
    Biton, V
    Rendell, M
    Vinik, A
    Giuliani, M
    Stevens, JC
    Barbano, R
    Dyck, PJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (17): : 2215 - 2221
  • [2] Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy
    Apfel, SC
    Kessler, JA
    Adornato, BT
    Litchy, WJ
    Sanders, C
    Rask, CA
    [J]. NEUROLOGY, 1998, 51 (03) : 695 - 702
  • [3] Neurotrophic factors and pain
    Apfel, SC
    [J]. CLINICAL JOURNAL OF PAIN, 2000, 16 (02) : S7 - S11
  • [4] Arima T, 1999, J OROFAC PAIN, V13, P104
  • [5] Duration and distribution of experimental muscle hyperalgesia in humans following combined infusions of serotonin and bradykinin
    Babenko, V
    Svensson, P
    Graven-Nielsen, T
    Drewes, AM
    Jensen, TS
    Arendt-Nielsen, L
    [J]. BRAIN RESEARCH, 2000, 853 (02) : 275 - 281
  • [6] Neurotrophic factors: Important regulators of nociceptive function
    Bennett, DLH
    [J]. NEUROSCIENTIST, 2001, 7 (01) : 13 - 17
  • [7] Sex differences in brainstem neural activation after injury to the TMJ region
    Bereiter, DA
    [J]. CELLS TISSUES ORGANS, 2001, 169 (03) : 226 - 237
  • [8] Nerve growth factor evokes hyperalgesia in mice lacking the low-affinity neurotrophin receptor p75
    Bergmann, I
    Reiter, R
    Toyka, KV
    Koltzenburg, M
    [J]. NEUROSCIENCE LETTERS, 1998, 255 (02) : 87 - 90
  • [9] Estrogen and neuroinflammation
    Bjorling, DE
    Wang, ZY
    [J]. UROLOGY, 2001, 57 (6A) : 40 - 46
  • [10] REFLEX EXCITATION OF MASTICATORY MUSCLES INDUCED BY ALGESIC CHEMICALS APPLIED TO THE TEMPOROMANDIBULAR-JOINT OF THE CAT
    BROTON, JG
    SESSLE, BJ
    [J]. ARCHIVES OF ORAL BIOLOGY, 1988, 33 (10) : 741 - 747